WaveMan · Form 4
Bjerkholt Eric insider trades
> Search tickers & screens ⌘K
LIVE

Bjerkholt Eric insider trades

Bjerkholt Eric has filed 52 Form 4s with the SEC that we hold, for Mirum Pharmaceuticals, Inc. (MIRM) (CHIEF FINANCIAL OFFICER), Cerus Corp (CERS) (Director), CalciMedica, Inc. (CALC) (Director) and KDNY (Chief Financial Officer), among 6 companies in all. Across all of them we count 15 purchases worth $447.8K and 20 sales worth $4.6M reported on Form 4. In the last 12 months: 0 purchases ($0) and 13 sales ($3.6M). The largest single trade was a sale of 9,943 shares of Mirum Pharmaceuticals, Inc. worth $978.1K, dated 2026-09-14. Of 1 sale filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-12-03 and the latest 2026-09-15.

Mirum Pharmaceuticals, Inc. (MIRM)

CHIEF FINANCIAL OFFICER · 19 filings · 17 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-09-11P, purchase reported on Form 410,000$296.5K2023-09-12
2024-03-18P, purchase reported on Form 42,000$51.6K2024-03-18
2024-03-27P, purchase reported on Form 42,000$49.6K2024-03-27
2025-08-11S, sale reported on Form 48,000-2025-08-12
2025-09-12S, sale reported on Form 49,578$728.0K2025-09-12
2026-01-22S, sale reported on Form 41,421$132.6K2026-01-23
2026-01-26S, sale reported on Form 41,053$101.3K2026-01-27
2026-03-16S, sale reported on Form 47,287$670.3K2026-03-17
2026-06-08S, sale reported on Form 41,175$110.4K2026-06-09
2026-06-08S, sale reported on Form 42,258$209.6K2026-06-09
2026-06-08S, sale reported on Form 41,567$149.1K2026-06-09
2026-07-06S, sale reported on Form 43,124$380.1K2026-07-08
2026-07-06S, sale reported on Form 41,048$128.3K2026-07-08
2026-07-06S, sale reported on Form 4528$65.4K2026-07-08
2026-07-06S, sale reported on Form 4300$37.5K2026-07-08
2026-08-11S, sale reported on Form 46,001$599.5K2026-08-12
2026-09-14S, sale reported on Form 49,943$978.1K2026-09-15

Cerus Corp (CERS)

Director · 10 filings · 5 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-05-23P, purchase reported on Form 45,000$10.0K2023-05-23
2023-08-21P, purchase reported on Form 410,000$17.2K2023-08-23
2023-12-13P, purchase reported on Form 410,000$16.2K2023-12-13
2024-12-12S, sale reported on Form 420,000$35.8K2024-12-16
2026-06-09S, sale reported on Form 420,454$53.2K2026-06-11

CalciMedica, Inc. (CALC)

Director · 9 filings · 9 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-05-16P, purchase reported on Form 4800$2.2K2023-05-18
2023-05-17P, purchase reported on Form 4200$5342023-05-18
2023-05-18P, purchase reported on Form 41$32023-05-22
2023-05-18P, purchase reported on Form 4300$8102023-05-18
2023-05-19P, purchase reported on Form 4199$5272023-05-22
2023-05-23P, purchase reported on Form 4500$1.6K2023-05-24
2023-05-30P, purchase reported on Form 45$162023-06-01
2023-05-31P, purchase reported on Form 4100$4092023-06-01
2023-05-31P, purchase reported on Form 4150$6302023-06-01

KDNY

Chief Financial Officer · 7 filings · 4 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-02-11S, sale reported on Form 4895$11.4K2022-02-14
2022-12-01S, sale reported on Form 45,770$128.6K2022-12-02
2023-01-31S, sale reported on Form 42,891$71.3K2023-02-02
2023-02-10S, sale reported on Form 4857$20.4K2023-02-15

Surrozen, Inc./DE (SRZN)

Director · 4 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Metagenomi Therapeutics, Inc. (MGX)

Director · 3 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1197350) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms